FIELD: organic chemistry, amino acids, pharmacy. SUBSTANCE: invention relates to group of novel compounds heterocyclic derivatives of glycyl-beta-alanine of the general formula (I): or pharmaceutical salt of this compound wherein is 5-8-membered monocyclic heterocyclic, optionally saturated ring comprising from 1 to 4 heteroatoms taken among the group including nitrogen and sulfur atoms being X1 is taken among the group including: CH, CH2, N, NH, O and S under condition that is not pyrrolidinyl when V means NH; A represents group of the formula: wherein Y1 is taken among group including N-R2 being R2 means hydrogen atom; R2 means hydrogen atom, R7 when is not common with R2; and R8 means hydrogen atom, alkyl substituted with alkoxy-group, or R2 in common with R7 forms 4-12-membered heterocycle comprising 2 nitrogen atoms optionally substituted with one or some substituents taken among group including hydroxy-, C1-C10-alkyl, halide, spirodioxalane; A means the group: wherein R2 in common with R7 form 5-8-membered heterocycle comprising two nitrogen atoms; R5 means hydrogen atom; R8 means alkyl optionally substituted with alkoxy- group; or A means group: wherein R2 in common with R7 form 5-8-membered heterocycle comprising 2 nitrogen atoms optionally substituted with hydroxy-group; R8 is alkyl substituted with alkoxy-group; V means N-(R6); R6 is hydrogen atom; Y and Z mean hydrogen atom; t = 0; n and p = 1, 2; R means X-R3 wherein X is O-; R3 is hydrogen atom, alkyl; R1 is taken among group including aryl, alkyl optionally mono- or multiple-substituted with halide, alkyl, hydroxy-group; monocyclic heterocycle; halogenalkyl; R11 means hydrogen atom, or pharmaceutically acceptable salt of this compound. Invention relates also to pharmaceutical composition eliciting properties of antagonist of αVβ3-integrin and to method for treatment of diseases mediated by αVβ3-integrin in mammals. EFFECT: valuable medicinal properties of compounds. 22 cl, 1 tbl, 60 ex
Title | Year | Author | Number |
---|---|---|---|
PARA-TERPHENYL COMPOUNDS, METHOD OF THEIR SYNTHESIS (VERSIONS) AND PHARMACEUTICAL COMPOSITION (VERSIONS) | 1997 |
|
RU2200730C2 |
BENZOTHIEPINES, PHARMACEUTICAL COMPOSITION BASED ON THEREOF, METHOD OF PROPHYLAXIS AND TREATMENT OF HYPERLIPIDEMIC STATE | 1997 |
|
RU2202549C2 |
NOVEL TRICYCLIC DERIVATIVES (VARIANTS), PHARMACEUTICAL COMPOSITION (VARIANTS), METHOD FOR INHIBITION OF IMMUNE RESPONSE OR TREATMENT AND/OR PROPHYLAXIS OF ALLERGIC DISEASES (VARIANTS) | 1999 |
|
RU2216533C2 |
3-(5)-HETEROARYL-SUBSTITUTED PYRAZOLES AS KINASE P38 INHIBITORS | 1998 |
|
RU2249591C2 |
AMINOPIPERIDINE DERIVATIVES AS CETP INACTIVATORS (CHOLESTEROL ESTER TRANSFER PROTEIN) | 2007 |
|
RU2442782C2 |
SULFATED AMINO ACID DERIVATIVES AND METALLOPROTEINASE INHIBITORS COMPRISING THEREOF | 1997 |
|
RU2198656C2 |
METHOD FOR PREPARING ENANTIOMERICALLY ENRICHED TETRAHYDROBENZOTHIEPINE OXIDES | 1998 |
|
RU2236406C2 |
SUBSTITUTED QUINOXALINE-TYPE PIPERIDINE COMPOUNDS AND USE THEREOF | 2008 |
|
RU2488585C2 |
DERIVATIVES OF PIPERAZINYLPENTAMIDE AND PHARMACEUTICAL COMPOSITION FOR INHIBITION OF HIV-PROTEASE ACTIVITY | 1992 |
|
RU2131416C1 |
INHIBITORS OF TH2-DIFFERENTIATION | 2000 |
|
RU2230551C2 |
Authors
Dates
2003-11-10—Published
1999-04-09—Filed